PRAME Immunohistochemistry in Thin Melanomas Compared to Melanocytic Nevi
PRAME (PReferentially expressed Antigen in Melanoma) immunohistochemistry has proven helpful in distinguishing malignant from benign melanocytic tumors. We studied PRAME IHC expression in 46 thin melanomas and 39 melanocytic nevi, mostly dysplastic nevi. Twenty-six percent (26.09%) of the melanomas...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-09-01
|
| Series: | Diagnostics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2075-4418/14/18/2015 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850261215440273408 |
|---|---|
| author | Iulia Zboraș Loredana Ungureanu Simona Șenilă Bobe Petrushev Paula Zamfir Doinița Crișan Flaviu Andrei Zaharie Ștefan Cristian Vesa Rodica Cosgarea |
| author_facet | Iulia Zboraș Loredana Ungureanu Simona Șenilă Bobe Petrushev Paula Zamfir Doinița Crișan Flaviu Andrei Zaharie Ștefan Cristian Vesa Rodica Cosgarea |
| author_sort | Iulia Zboraș |
| collection | DOAJ |
| description | PRAME (PReferentially expressed Antigen in Melanoma) immunohistochemistry has proven helpful in distinguishing malignant from benign melanocytic tumors. We studied PRAME IHC expression in 46 thin melanomas and 39 melanocytic nevi, mostly dysplastic nevi. Twenty-six percent (26.09%) of the melanomas showed diffuse PRAME staining in over 76% of the tumor cells (4+), and 34.78% of the melanomas showed PRAME expression in over 51% of the tumor cells (3+ or 4+), while 8% were entirely negative for PRAME. No melanocytic nevi were PRAME 4+ or 3+. More than half of the nevi (64%) were entirely negative for PRAME staining, and 36% of the nevi showed staining expression in 1–25% (1+) or 26–50% of the cells (2+). No nevi were stained with a color intensity of 3, while 16.67% of the melanomas were stained with this color intensity. Most nevi (78.57%) were stained with an intensity of 1. With a lower positivity threshold, sensitivity increases with still reasonable specificity. The best accuracy was obtained for the 2+ positivity threshold. In conclusion, PRAME staining helps distinguish thin melanomas from dysplastic nevi. However, the threshold of positivity should be lowered in order not to miss thin melanomas. |
| format | Article |
| id | doaj-art-63268d3e88ff4e3a940404cb93f28e9c |
| institution | OA Journals |
| issn | 2075-4418 |
| language | English |
| publishDate | 2024-09-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Diagnostics |
| spelling | doaj-art-63268d3e88ff4e3a940404cb93f28e9c2025-08-20T01:55:28ZengMDPI AGDiagnostics2075-44182024-09-011418201510.3390/diagnostics14182015PRAME Immunohistochemistry in Thin Melanomas Compared to Melanocytic NeviIulia Zboraș0Loredana Ungureanu1Simona Șenilă2Bobe Petrushev3Paula Zamfir4Doinița Crișan5Flaviu Andrei Zaharie6Ștefan Cristian Vesa7Rodica Cosgarea8Department of Dermatology, “Iuliu Hațieganu” University of Medicine and Pharmacy, 400006 Cluj-Napoca, RomaniaDepartment of Dermatology, “Iuliu Hațieganu” University of Medicine and Pharmacy, 400006 Cluj-Napoca, RomaniaDepartment of Dermatology, “Iuliu Hațieganu” University of Medicine and Pharmacy, 400006 Cluj-Napoca, RomaniaDepartment of Pathology, Regional Institute of Gastroenterology and Hepatology, 400162 Cluj-Napoca, RomaniaDepartment of Pathology, Regional Institute of Gastroenterology and Hepatology, 400162 Cluj-Napoca, RomaniaDepartment of Pathology, “Iuliu Hațieganu” University of Medicine and Pharmacy, 400006 Cluj-Napoca, RomaniaFaculty of Medicine, “Iuliu Hațieganu” University of Medicine and Pharmacy, 400012 Cluj-Napoca, RomaniaDepartment of Pharmacology, Toxicology and Clinical Pharmacology, “Iuliu Hațieganu” University of Medicine and Pharmacy, 400337 Cluj-Napoca, RomaniaDepartment of Dermatology, “Iuliu Hațieganu” University of Medicine and Pharmacy, 400006 Cluj-Napoca, RomaniaPRAME (PReferentially expressed Antigen in Melanoma) immunohistochemistry has proven helpful in distinguishing malignant from benign melanocytic tumors. We studied PRAME IHC expression in 46 thin melanomas and 39 melanocytic nevi, mostly dysplastic nevi. Twenty-six percent (26.09%) of the melanomas showed diffuse PRAME staining in over 76% of the tumor cells (4+), and 34.78% of the melanomas showed PRAME expression in over 51% of the tumor cells (3+ or 4+), while 8% were entirely negative for PRAME. No melanocytic nevi were PRAME 4+ or 3+. More than half of the nevi (64%) were entirely negative for PRAME staining, and 36% of the nevi showed staining expression in 1–25% (1+) or 26–50% of the cells (2+). No nevi were stained with a color intensity of 3, while 16.67% of the melanomas were stained with this color intensity. Most nevi (78.57%) were stained with an intensity of 1. With a lower positivity threshold, sensitivity increases with still reasonable specificity. The best accuracy was obtained for the 2+ positivity threshold. In conclusion, PRAME staining helps distinguish thin melanomas from dysplastic nevi. However, the threshold of positivity should be lowered in order not to miss thin melanomas.https://www.mdpi.com/2075-4418/14/18/2015PRAMEimmunohistochemistrymelanomanevus |
| spellingShingle | Iulia Zboraș Loredana Ungureanu Simona Șenilă Bobe Petrushev Paula Zamfir Doinița Crișan Flaviu Andrei Zaharie Ștefan Cristian Vesa Rodica Cosgarea PRAME Immunohistochemistry in Thin Melanomas Compared to Melanocytic Nevi Diagnostics PRAME immunohistochemistry melanoma nevus |
| title | PRAME Immunohistochemistry in Thin Melanomas Compared to Melanocytic Nevi |
| title_full | PRAME Immunohistochemistry in Thin Melanomas Compared to Melanocytic Nevi |
| title_fullStr | PRAME Immunohistochemistry in Thin Melanomas Compared to Melanocytic Nevi |
| title_full_unstemmed | PRAME Immunohistochemistry in Thin Melanomas Compared to Melanocytic Nevi |
| title_short | PRAME Immunohistochemistry in Thin Melanomas Compared to Melanocytic Nevi |
| title_sort | prame immunohistochemistry in thin melanomas compared to melanocytic nevi |
| topic | PRAME immunohistochemistry melanoma nevus |
| url | https://www.mdpi.com/2075-4418/14/18/2015 |
| work_keys_str_mv | AT iuliazboras prameimmunohistochemistryinthinmelanomascomparedtomelanocyticnevi AT loredanaungureanu prameimmunohistochemistryinthinmelanomascomparedtomelanocyticnevi AT simonasenila prameimmunohistochemistryinthinmelanomascomparedtomelanocyticnevi AT bobepetrushev prameimmunohistochemistryinthinmelanomascomparedtomelanocyticnevi AT paulazamfir prameimmunohistochemistryinthinmelanomascomparedtomelanocyticnevi AT doinitacrisan prameimmunohistochemistryinthinmelanomascomparedtomelanocyticnevi AT flaviuandreizaharie prameimmunohistochemistryinthinmelanomascomparedtomelanocyticnevi AT stefancristianvesa prameimmunohistochemistryinthinmelanomascomparedtomelanocyticnevi AT rodicacosgarea prameimmunohistochemistryinthinmelanomascomparedtomelanocyticnevi |